VAERS Explorer
Back to explore

Report #2869607

Received Oct 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
IN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Product preparation issue

Symptom narrative

patient received adjuvant without powder; patient received adjuvant without powder; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a elderly male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient received adjuvant without powder) and inappropriate dose of vaccine administered (Verbatim: patient received adjuvant without powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 15-OCT-2025 Healthcare professional wanted to know if patient could now receive a full dose of Arexvy. It was the reporter who reported it who administered to patient. No lot or expiration date was available during call with the reporter. The batch number was not provided upon follow- up with the reporter.